SARAH ESTRADA: Open Payments
NPI 1295394237 · CHAMBLEE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,506 in 156 payments from 26 companies in 2025. Trend: 2023 $3,602 · 2024 $2,918 · 2025 $3,506
Food & beverage: $3,410Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 67 | $1,187 |
| Lundbeck LLC | 11 | $265 |
| UCB, Inc. | 11 | $261 |
| Novartis Pharmaceuticals Corporation | 10 | $252 |
| Teva Pharmaceuticals USA, Inc. | 8 | $245 |
| Eisai Inc. | 5 | $228 |
| Axsome Therapeutics, Inc. | 6 | $163 |
| Biogen, Inc. | 6 | $144 |
| Otsuka America Pharmaceutical, Inc. | 5 | $125 |
| Neurocrine BioSciences, Inc. | 3 | $93 |
Products named: QULIPTA, Leqembi, VYEPTI, KESIMPTA, Symbravo, BOTOX, REXULTI, UBRELVY.
Industry payments across GA — which companies pay providers there.
